Drug Dissolution Methods

**Overview**
This data package provides information on inactive ingredients present in FDA-approved drug products as well as dissolution methods presently recommended by the Food and Drug Administration (FDA) for drug products that do not have a dissolution test method in the United States Pharmacopeia (USP). It also includes fraction of the potentially hazardous products with hidden ingredients marketed to consumers on the internet and in retail establishments.

**Description**
This data package gives access to FDA inactive ingredients data. For new drug development purposes, once an inactive ingredient has appeared in an approved drug product for a particular route of administration, the inactive ingredient is not considered new and may require a less extensive review the next time it is included in a new drug product. The data package also includes the FDA Drug Dissolution Methods data that FDA is providing to aid industry personnel in developing generic drug products. The data package also enlists potentially hazardous products with hidden ingredients marketed to consumers on the internet and in retail establishments.

**Benefits**
- full access to fda drug dissolution methods
- full access to current fda drugs inactive ingredients database.
- access to tainted products marketed as dietary supplements constituted from fda alerts and warning.

**License Information**
The use of John Snow Labs datasets is free for personal and research purposes. For commercial use please subscribe to the [Data Library](https://www.johnsnowlabs.com/marketplace/) on John Snow Labs website. The subscription will allow you to use all John Snow Labs datasets and data packages for commercial purposes.

**Included Datasets**
- [Drugs Inactive Ingredients Database](https://www.johnsnowlabs.com/marketplace/drugs-inactive-ingredients-database)
- The Inactive Ingredient Database provides information on inactive ingredients present in Food and Drug Administration (FDA) approved drug products. This information can be used by industry as an aid in developing drug products.
- [FDA Drug Dissolution Methods](https://www.johnsnowlabs.com/marketplace/fda-drug-dissolution-methods)
- For a drug product that does not have a dissolution test method in the United States Pharmacopeia (USP), the Food and Drug Administration (FDA) Dissolution Methods Database provides information on dissolution methods presently recommended by the Division of Bioequivalence, Office of Generic Drugs.
- [Tainted Products Marketed as Dietary Supplements](https://www.johnsnowlabs.com/marketplace/tainted-products-marketed-as-dietary-supplements)
- The tainted products marketed as dietary supplements dataset includes a small fraction of the potentially hazardous products with hidden ingredients marketed to consumers on the internet and in retail establishments.

**Data Engineering Overview**
**We deliver high-quality data**
- Each dataset goes through 3 levels of quality review
- 2 Manual reviews are done by domain experts
- Then, an automated set of 60+ validations enforces every datum matches metadata & defined constraints
- Data is normalized into one unified type system
- All dates, unites, codes, currencies look the same
- All null values are normalized to the same value
- All dataset and field names are SQL and Hive compliant
- Data and Metadata
- Data is available in both CSV and Apache Parquet format, optimized for high read performance on distributed Hadoop, Spark & MPP clusters
- Metadata is provided in the open Frictionless Data standard, and its every field is normalized & validated
- Data Updates
- Data updates support replace-on-update: outdated foreign keys are deprecated, not deleted

**Our data is curated and enriched by domain experts**

Each dataset is manually curated by our team of doctors, pharmacists, public health & medical billing experts:
- Field names, descriptions, and normalized values are chosen by people who actually understand their meaning
- Healthcare & life science experts add categories, search keywords, descriptions and more to each dataset
- Both manual and automated data enrichment supported for clinical codes, providers, drugs, and geo-locations
- The data is always kept up to date – even when the source requires manual effort to get updates
- Support for data subscribers is provided directly by the domain experts who curated the data sets
- Every data source’s license is manually verified to allow for royalty-free commercial use and redistribution.

**Need Help?**
If you have questions about our products, contact us at [[e-mail]](mailto:[e-mail]).

搜集汇总

背景与挑战

背景概述

该数据集提供FDA批准的药物非活性成分信息、未收录于美国药典的药物溶出测试方法，以及含隐藏成分的潜在危险膳食补充剂产品数据。数据经过专业团队三级质量审核，支持科研和商业用途。